van Dijk Marcus Antonius
SEC CIK 1881659 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | CSO | 51.6K | — | — | 2 | 2023-01-09 | 2023-01-09 |
Most active insiders at INKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Barbara | Dir | — | $46.6K |
| 2 | Holcomb John Bradley | Dir | — | — |
| 3 | Kadlec Robert Peter | Dir | — | — |
| 4 | Behner Peter | Dir | — | — |
| 5 | Buell Jennifer | CEO | — | — |
| 6 | Corvese Brian | Dir | — | — |
| 7 | WIINBERG ULF | Dir | — | — |
van Dijk Marcus Antonius made no open-market trades at INKT in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-12 | 2023-01-09 | INKT | MiNK Therapeutics, Inc. | van Dijk Marcus Antonius | CSO | A - Grant | $2.32 | +51.6K | 51.6K | New | +$119.8K | |
| 2023-01-12 | 2023-01-09 | INKT | MiNK Therapeutics, Inc. | van Dijk Marcus Antonius | CSO | F - Tax | $2.32 | -24.3K | 27.4K | -47% | -$56.3K |
Purchase Sale Sale after option exercise All abbreviations